Liquid biopsy (cancer screening)
“Moreover, changes in cfDNA levels and epigenetics hold promise for improving the diagnosis, prognosis, and treatment of neurological disorders, including traumatic brain injury, Alzheimer's disease, and multiple sclerosis.”